1 / 1

Impact of Finasteride on Prostate Cancer Biopsy Outcomes in Men: PCPT Results Analysis

The Prostate Cancer Prevention Trial (PCPT) results indicate the impact of finasteride on biopsy rates and prostate cancer diagnoses. This analysis, presented by Goetzl MA and Holzbeierlein JM (2006), provides crucial insights into how finasteride serves as a chemopreventive agent and its implications for urologic practice. Data reveal significant differences in the number of men undergoing biopsies and subsequently diagnosed with prostate cancer, highlighting finasteride's role in preventive strategies.

ira
Download Presentation

Impact of Finasteride on Prostate Cancer Biopsy Outcomes in Men: PCPT Results Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 1 Results from the Prostate Cancer Prevention Trial showing the numbers of men who underwent biopsy in each group and the numbers subsequently diagnosed with prostate cancer Goetzl MA and Holzbeierlein JM (2006) Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice Nat Clin Pract Urol3:422–429 doi:10.1038/ncpuro574

More Related